Document:

THIS WARRANT AND THE SHARES  ISSUABLE  UPON THE EXERCISE OF THIS
      WARRANT HAVE NOT BEEN  REGISTERED  UNDER THE  SECURITIES  ACT OF
      1933,  AS AMENDED.  EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A
      SECURITIES  PURCHASE  AGREEMENT  DATED AS OF SEPTEMBER 12, 2006,
      NEITHER  THIS  WARRANT  NOR  ANY OF  SUCH  SHARES  MAY BE  SOLD,
      TRANSFERRED   OR  ASSIGNED  IN  THE  ABSENCE  OF  AN   EFFECTIVE
      REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER SAID ACT OR, AN
      OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE,  CUSTOMARY FOR
      OPINIONS   OF   COUNSEL   IN   COMPARABLE   TRANSACTIONS,   THAT
      REGISTRATION  IS NOT  REQUIRED  UNDER  SUCH ACT OR  UNLESS  SOLD
      PURSUANT TO RULE 144 OR REGULATION S UNDER SUCH ACT.

                                                                  Right to
                                                                  Purchase
                                                                  200,000 Shares
                                                                  of Common
                                                                  Stock, par
                                                                  value $.001
                                                                  per share

                             STOCK PURCHASE WARRANT

      THIS CERTIFIES THAT, for value received, New Millennium Capital Partners
II, LLC or its registered assigns, is entitled to purchase from Advanced
Biophotonics Inc., a Delaware corporation (the "Company"), at any time or from
time to time during the period specified in Paragraph 2 hereof, 200,000 fully
paid and nonassessable shares of the Company's Common Stock, par value $.001 per
share (the "Common Stock"), at an exercise price per share equal to $.30 (the
"Exercise Price"). The term "Warrant Shares," as used herein, refers to the
shares of Common Stock purchasable hereunder. The Warrant Shares and the
Exercise Price are subject to adjustment as provided in Paragraph 4 hereof. The
term "Warrants" means this Warrant and the other warrants issued pursuant to
that certain Securities Purchase Agreement, dated September 12, 2006, by and
among the Company and the Buyers listed on the execution page thereof (the
"Securities Purchase Agreement").

      This Warrant is subject to the following terms, provisions, and
conditions:

<PAGE>

      1. Manner of Exercise; Issuance of Certificates; Payment for Shares.

      Subject to the provisions hereof, this Warrant may be exercised by the
holder hereof, in whole or in part, by the surrender of this Warrant, together
with a completed exercise agreement in the form attached hereto (the "Exercise
Agreement"), to the Company during normal business hours on any business day at
the Company's principal executive offices (or such other office or agency of the
Company as it may designate by notice to the holder hereof), and upon (i)
payment to the Company in cash, by certified or official bank check or by wire
transfer for the account of the Company of the Exercise Price for the Warrant
Shares specified in the Exercise Agreement or (ii) if the resale of the Warrant
Shares by the holder is not then registered pursuant to an effective
registration statement under the Securities Act of 1933, as amended (the
"Securities Act"), delivery to the Company of a written notice of an election to
effect a "Cashless Exercise" (as defined in Section 11(c) below) for the Warrant
Shares specified in the Exercise Agreement. The Warrant Shares so purchased
shall be deemed to be issued to the holder hereof or such holder's designee, as
the record owner of such shares, as of the close of business on the date on
which this Warrant shall have been surrendered, the completed Exercise Agreement
shall have been delivered, and payment shall have been made for such shares as
set forth above. Certificates for the Warrant Shares so purchased, representing
the aggregate number of shares specified in the Exercise Agreement, shall be
delivered to the holder hereof within a reasonable time, not exceeding five (5)
business days, after this Warrant shall have been so exercised. The certificates
so delivered shall be in such denominations as may be requested by the holder
hereof and shall be registered in the name of such holder or such other name as
shall be designated by such holder. If this Warrant shall have been exercised
only in part, then, unless this Warrant has expired, the Company shall, at its
expense, at the time of delivery of such certificates, deliver to the holder a
new Warrant representing the number of shares with respect to which this Warrant
shall not then have been exercised. In addition to all other available remedies
at law or in equity, if the Company fails to deliver certificates for the
Warrant Shares within five (5) business days after this Warrant is exercised,
then the Company shall pay to the holder in cash a penalty (the "Penalty") equal
to 2% of the number of Warrant Shares that the holder is entitled to multiplied
by the Market Price (as hereinafter defined) for each day that the Company fails
to deliver certificates for the Warrant Shares. For example, if the holder is
entitled to 100,000 Warrant Shares and the Market Price is $2.00, then the
Company shall pay to the holder $4,000 for each day that the Company fails to
deliver certificates for the Warrant Shares. The Penalty shall be paid to the
holder by the fifth day of the month following the month in which it has
accrued.

      Notwithstanding anything in this Warrant to the contrary, in no event
shall the holder of this Warrant be entitled to exercise a number of Warrants
(or portions thereof) in excess of the number of Warrants (or portions thereof)
upon exercise of which the sum of (i) the number of shares of Common Stock
beneficially owned by the holder and its affiliates (other than shares of Common
Stock which may be deemed beneficially owned through the ownership of the
unexercised Warrants and the unexercised or unconverted portion of any other
securities of the Company (including the Notes (as defined in the Securities
Purchase Agreement)) subject to a limitation on conversion or exercise analogous
to the limitation contained herein) and (ii) the number of shares of Common
Stock issuable upon exercise of the Warrants (or portions thereof) with respect
to which the determination described herein is being made, would result in
beneficial ownership by the holder and its affiliates of more than 4.9% of the
outstanding shares of Common Stock. For purposes of the immediately preceding
sentence, beneficial ownership shall be determined in accordance with Section
13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13D-G
thereunder, except as otherwise provided in clause (i) of the preceding
sentence. Notwithstanding anything to the contrary contained herein, the
limitation on exercise of this Warrant set forth herein may not be amended
without (i) the written consent of the holder hereof and the Company and (ii)
the approval of a majority of shareholders of the Company.

                                       2
<PAGE>

      2. Period of Exercise.

      This Warrant is exercisable at any time or from time to time on or after
the date on which this Warrant is issued and delivered pursuant to the terms of
the Securities Purchase Agreement and before 6:00 p.m., New York, New York time
on the seventh (7th) anniversary of the date of issuance (the "Exercise
Period").

      3. Certain Agreements of the Company.

      The Company hereby covenants and agrees as follows:

            (a) Shares to be Fully Paid. Subject to Stockholder Approval (as
      such term is defined in Section 4(n) of the Securities Purchase
      Agreement), all Warrant Shares will, upon issuance in accordance with the
      terms of this Warrant, be validly issued, fully paid, and nonassessable
      and free from all taxes, liens, and charges with respect to the issue
      thereof.

            (b) Reservation of Shares. Subject to Stockholder Approval (as such
      term is defined in Section 4(n) of the Securities Purchase Agreement),
      during the Exercise Period, the Company shall at all times have
      authorized, and reserved for the purpose of issuance upon exercise of this
      Warrant, a sufficient number of shares of Common Stock to provide for the
      exercise of this Warrant.

            (c) Listing. The Company shall promptly secure the listing of the
      shares of Common Stock issuable upon exercise of the Warrant upon each
      national securities exchange or automated quotation system, if any, upon
      which shares of Common Stock are then listed (subject to official notice
      of issuance upon exercise of this Warrant) and shall maintain, so long as
      any other shares of Common Stock shall be so listed, such listing of all
      shares of Common Stock from time to time issuable upon the exercise of
      this Warrant; and the Company shall so list on each national securities
      exchange or automated quotation system, as the case may be, and shall
      maintain such listing of, any other shares of capital stock of the Company
      issuable upon the exercise of this Warrant if and so long as any shares of
      the same class shall be listed on such national securities exchange or
      automated quotation system.

            (d) Certain Actions Prohibited. The Company will not, by amendment
      of its charter or through any reorganization, transfer of assets,
      consolidation, merger, dissolution, issue or sale of securities, or any
      other voluntary action, avoid or seek to avoid the observance or
      performance of any of the terms to be observed or performed by it
      hereunder, but will at all times in good faith assist in the carrying out
      of all the provisions of this Warrant and in the taking of all such action
      as may reasonably be requested by the holder of this Warrant in order to
      protect the exercise privilege of the holder of this Warrant against
      dilution or other impairment, consistent with the tenor and purpose of
      this Warrant. Without limiting the generality of the foregoing, the
      Company (i) will not increase the par value of any shares of Common Stock
      receivable upon the exercise of this Warrant above the Exercise Price then
      in effect, and (ii) will take all such actions as may be necessary or
      appropriate in order that the Company may validly and legally issue fully
      paid and nonassessable shares of Common Stock upon the exercise of this
      Warrant.

            (e) Successors and Assigns. This Warrant will be binding upon any
      entity succeeding to the Company by merger, consolidation, or acquisition
      of all or substantially all the Company's assets.

                                       3
<PAGE>

      4. Antidilution Provisions.

      During the Exercise Period, the Exercise Price and the number of Warrant
Shares shall be subject to adjustment from time to time as provided in this
Paragraph 4.

      In the event that any adjustment of the Exercise Price as required herein
results in a fraction of a cent, such Exercise Price shall be rounded up to the
nearest cent.

            (a) Adjustment of Exercise Price and Number of Shares upon Issuance
      of Common Stock. Except as otherwise provided in Paragraphs 4(c) and 4(e)
      hereof, if and whenever on or after the date of issuance of this Warrant,
      the Company issues or sells, or in accordance with Paragraph 4(b) hereof
      is deemed to have issued or sold, any shares of Common Stock for no
      consideration or for a consideration per share (before deduction of
      reasonable expenses or commissions or underwriting discounts or allowances
      in connection therewith) less than the Market Price on the date of
      issuance (a "Dilutive Issuance"), then immediately upon the Dilutive
      Issuance, the Exercise Price will be reduced to a price determined by
      multiplying the Exercise Price in effect immediately prior to the Dilutive
      Issuance by a fraction, (i) the numerator of which is an amount equal to
      the sum of (x) the number of shares of Common Stock actually outstanding
      immediately prior to the Dilutive Issuance, plus (y) the quotient of the
      aggregate consideration, calculated as set forth in Paragraph 4(b) hereof,
      received by the Company upon such Dilutive Issuance divided by the Market
      Price in effect immediately prior to the Dilutive Issuance, and (ii) the
      denominator of which is the total number of shares of Common Stock Deemed
      Outstanding (as defined below) immediately after the Dilutive Issuance.

            (b) Effect on Exercise Price of Certain Events. For purposes of
      determining the adjusted Exercise Price under Paragraph 4(a) hereof, the
      following will be applicable:

                  (i) Issuance of Rights or Options. If the Company in any
            manner issues or grants any warrants, rights or options, whether or
            not immediately exercisable, to subscribe for or to purchase Common
            Stock or other securities convertible into or exchangeable for
            Common Stock ("Convertible Securities") (such warrants, rights and
            options to purchase Common Stock or Convertible Securities are
            hereinafter referred to as "Options") and the price per share for
            which Common Stock is issuable upon the exercise of such Options is
            less than the Market Price on the date of issuance or grant of such
            Options, then the maximum total number of shares of Common Stock
            issuable upon the exercise of all such Options will, as of the date
            of the issuance or grant of such Options, be deemed to be
            outstanding and to have been issued and sold by the Company for such
            price per share. For purposes of the preceding sentence, the "price
            per share for which Common Stock is issuable upon the exercise of
            such Options" is determined by dividing (i) the total amount, if
            any, received or receivable by the Company as consideration for the
            issuance or granting of all such Options, plus the minimum aggregate
            amount of additional consideration, if any, payable to the Company
            upon the exercise of all such Options, plus, in the case of
            Convertible Securities issuable upon the exercise of such Options,
            the minimum aggregate amount of additional consideration payable
            upon the conversion or exchange thereof at the time such Convertible
            Securities first become convertible or exchangeable, by (ii) the
            maximum total number of shares of Common Stock issuable upon the
            exercise of all such Options (assuming full conversion of
            Convertible Securities, if applicable). No further adjustment to the
            Exercise Price will be made upon the actual issuance of such Common
            Stock upon the exercise of such Options or upon the conversion or
            exchange of Convertible Securities issuable upon exercise of such
            Options.

                                       4
<PAGE>

                  (ii) Issuance of Convertible Securities. If the Company in any
            manner issues or sells any Convertible Securities, whether or not
            immediately convertible (other than where the same are issuable upon
            the exercise of Options) and the price per share for which Common
            Stock is issuable upon such conversion or exchange is less than the
            Market Price on the date of issuance, then the maximum total number
            of shares of Common Stock issuable upon the conversion or exchange
            of all such Convertible Securities will, as of the date of the
            issuance of such Convertible Securities, be deemed to be outstanding
            and to have been issued and sold by the Company for such price per
            share. For the purposes of the preceding sentence, the "price per
            share for which Common Stock is issuable upon such conversion or
            exchange" is determined by dividing (i) the total amount, if any,
            received or receivable by the Company as consideration for the
            issuance or sale of all such Convertible Securities, plus the
            minimum aggregate amount of additional consideration, if any,
            payable to the Company upon the conversion or exchange thereof at
            the time such Convertible Securities first become convertible or
            exchangeable, by (ii) the maximum total number of shares of Common
            Stock issuable upon the conversion or exchange of all such
            Convertible Securities. No further adjustment to the Exercise Price
            will be made upon the actual issuance of such Common Stock upon
            conversion or exchange of such Convertible Securities.

                  (iii) Change in Option Price or Conversion Rate. If there is a
            change at any time in (i) the amount of additional consideration
            payable to the Company upon the exercise of any Options; (ii) the
            amount of additional consideration, if any, payable to the Company
            upon the conversion or exchange of any Convertible Securities; or
            (iii) the rate at which any Convertible Securities are convertible
            into or exchangeable for Common Stock (other than under or by reason
            of provisions designed to protect against dilution), the Exercise
            Price in effect at the time of such change will be readjusted to the
            Exercise Price which would have been in effect at such time had such
            Options or Convertible Securities still outstanding provided for
            such changed additional consideration or changed conversion rate, as
            the case may be, at the time initially granted, issued or sold.

                  (iv) Treatment of Expired Options and Unexercised Convertible
            Securities. If, in any case, the total number of shares of Common
            Stock issuable upon exercise of any Option or upon conversion or
            exchange of any Convertible Securities is not, in fact, issued and
            the rights to exercise such Option or to convert or exchange such
            Convertible Securities shall have expired or terminated, the
            Exercise Price then in effect will be readjusted to the Exercise
            Price which would have been in effect at the time of such expiration
            or termination had such Option or Convertible Securities, to the
            extent outstanding immediately prior to such expiration or
            termination (other than in respect of the actual number of shares of
            Common Stock issued upon exercise or conversion thereof), never been
            issued.

                  (v) Calculation of Consideration Received. If any Common
            Stock, Options or Convertible Securities are issued, granted or sold
            for cash, the consideration received therefor for purposes of this
            Warrant will be the amount received by the Company therefor, before
            deduction of reasonable commissions, underwriting discounts or
            allowances or other reasonable expenses paid or incurred by the
            Company in connection with such issuance, grant or sale. In case any
            Common Stock, Options or Convertible Securities are issued or sold
            for a consideration part or all of which shall be other than cash,
            the amount of the consideration other than cash received by the
            Company will be the fair value of such consideration, except where
            such consideration consists of securities, in which case the amount
            of consideration received by the Company will be the Market Price
            thereof as of the date of receipt. In case any Common Stock, Options
            or Convertible Securities are issued in connection with any
            acquisition, merger or consolidation in which the Company is the
            surviving corporation, the amount of consideration therefor will be
            deemed to be the fair value of such portion of the net assets and
            business of the non-surviving corporation as is attributable to such
            Common Stock, Options or Convertible Securities, as the case may be.
            The fair value of any consideration other than cash or securities
            will be determined in good faith by the Board of Directors of the
            Company.

                                       5
<PAGE>

                  (vi) Exceptions to Adjustment of Exercise Price. No adjustment
            to the Exercise Price will be made (i) upon the exercise of any
            warrants, options or convertible securities granted, issued and
            outstanding on the date of issuance of this Warrant; (ii) upon the
            grant or exercise of any stock or options which may hereafter be
            granted or exercised under any employee benefit plan, stock option
            plan or restricted stock plan of the Company now existing or to be
            implemented in the future, so long as the issuance of such stock or
            options is approved by a majority of the independent members of the
            Board of Directors of the Company or a majority of the members of a
            committee of independent directors established for such purpose; or
            (iii) upon the exercise of the Warrants.

            (c) Subdivision or Combination of Common Stock. If the Company at
      any time subdivides (by any stock split, stock dividend, recapitalization,
      reorganization, reclassification or otherwise) the shares of Common Stock
      acquirable hereunder into a greater number of shares, then, after the date
      of record for effecting such subdivision, the Exercise Price in effect
      immediately prior to such subdivision will be proportionately reduced. If
      the Company at any time combines (by reverse stock split,
      recapitalization, reorganization, reclassification or otherwise) the
      shares of Common Stock acquirable hereunder into a smaller number of
      shares, then, after the date of record for effecting such combination, the
      Exercise Price in effect immediately prior to such combination will be
      proportionately increased.

            (d) Adjustment in Number of Shares. Upon each adjustment of the
      Exercise Price pursuant to the provisions of this Paragraph 4, the number
      of shares of Common Stock issuable upon exercise of this Warrant shall be
      adjusted by multiplying a number equal to the Exercise Price in effect
      immediately prior to such adjustment by the number of shares of Common
      Stock issuable upon exercise of this Warrant immediately prior to such
      adjustment and dividing the product so obtained by the adjusted Exercise
      Price.

            (e) Consolidation, Merger or Sale. In case of any consolidation of
      the Company with, or merger of the Company into any other corporation, or
      in case of any sale or conveyance of all or substantially all of the
      assets of the Company other than in connection with a plan of complete
      liquidation of the Company, then as a condition of such consolidation,
      merger or sale or conveyance, adequate provision will be made whereby the
      holder of this Warrant will have the right to acquire and receive upon
      exercise of this Warrant in lieu of the shares of Common Stock immediately
      theretofore acquirable upon the exercise of this Warrant, such shares of
      stock, securities or assets as may be issued or payable with respect to or
      in exchange for the number of shares of Common Stock immediately
      theretofore acquirable and receivable upon exercise of this Warrant had
      such consolidation, merger or sale or conveyance not taken place. In any
      such case, the Company will make appropriate provision to insure that the
      provisions of this Paragraph 4 hereof will thereafter be applicable as
      nearly as may be in relation to any shares of stock or securities
      thereafter deliverable upon the exercise of this Warrant. The Company will
      not effect any consolidation, merger or sale or conveyance unless prior to
      the consummation thereof, the successor corporation (if other than the
      Company) assumes by written instrument the obligations under this
      Paragraph 4 and the obligations to deliver to the holder of this Warrant
      such shares of stock, securities or assets as, in accordance with the
      foregoing provisions, the holder may be entitled to acquire.

                                       6
<PAGE>

            (f) Distribution of Assets. In case the Company shall declare or
      make any distribution of its assets (including cash) to holders of Common
      Stock as a partial liquidating dividend, by way of return of capital or
      otherwise, then, after the date of record for determining shareholders
      entitled to such distribution, but prior to the date of distribution, the
      holder of this Warrant shall be entitled upon exercise of this Warrant for
      the purchase of any or all of the shares of Common Stock subject hereto,
      to receive the amount of such assets which would have been payable to the
      holder had such holder been the holder of such shares of Common Stock on
      the record date for the determination of shareholders entitled to such
      distribution.

            (g) Notice of Adjustment. Upon the occurrence of any event which
      requires any adjustment of the Exercise Price, then, and in each such
      case, the Company shall give notice thereof to the holder of this Warrant,
      which notice shall state the Exercise Price resulting from such adjustment
      and the increase or decrease in the number of Warrant Shares purchasable
      at such price upon exercise, setting forth in reasonable detail the method
      of calculation and the facts upon which such calculation is based. Such
      calculation shall be certified by the Chief Financial Officer of the
      Company.

            (h) Minimum Adjustment of Exercise Price. No adjustment of the
      Exercise Price shall be made in an amount of less than 1% of the Exercise
      Price in effect at the time such adjustment is otherwise required to be
      made, but any such lesser adjustment shall be carried forward and shall be
      made at the time and together with the next subsequent adjustment which,
      together with any adjustments so carried forward, shall amount to not less
      than 1% of such Exercise Price.

            (i) No Fractional Shares. No fractional shares of Common Stock are
      to be issued upon the exercise of this Warrant, but the Company shall pay
      a cash adjustment in respect of any fractional share which would otherwise
      be issuable in an amount equal to the same fraction of the Market Price of
      a share of Common Stock on the date of such exercise.

            (j) Other Notices. In case at any time:

                  (i) the Company shall declare any dividend upon the Common
            Stock payable in shares of stock of any class or make any other
            distribution (including dividends or distributions payable in cash
            out of retained earnings) to the holders of the Common Stock;

                  (ii) the Company shall offer for subscription pro rata to the
            holders of the Common Stock any additional shares of stock of any
            class or other rights;

                                       7
<PAGE>

                  (iii) there shall be any capital reorganization of the
            Company, or reclassification of the Common Stock, or consolidation
            or merger of the Company with or into, or sale of all or
            substantially all its assets to, another corporation or entity; or

                  (iv) there shall be a voluntary or involuntary dissolution,
            liquidation or winding up of the Company;

then, in each such case, the Company shall give to the holder of this Warrant
(a) notice of the date on which the books of the Company shall close or a record
shall be taken for determining the holders of Common Stock entitled to receive
any such dividend, distribution, or subscription rights or for determining the
holders of Common Stock entitled to vote in respect of any such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or
winding-up and (b) in the case of any such reorganization, reclassification,
consolidation, merger, sale, dissolution, liquidation or winding-up, notice of
the date (or, if not then known, a reasonable approximation thereof by the
Company) when the same shall take place. Such notice shall also specify the date
on which the holders of Common Stock shall be entitled to receive such dividend,
distribution, or subscription rights or to exchange their Common Stock for stock
or other securities or property deliverable upon such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation, or
winding-up, as the case may be. Such notice shall be given at least 30 days
prior to the record date or the date on which the Company's books are closed in
respect thereto. Failure to give any such notice or any defect therein shall not
affect the validity of the proceedings referred to in clauses (i), (ii), (iii)
and (iv) above.

            (k) Certain Events. If any event occurs of the type contemplated by
      the adjustment provisions of this Paragraph 4 but not expressly provided
      for by such provisions, the Company will give notice of such event as
      provided in Paragraph 4(g) hereof, and the Company's Board of Directors
      will make an appropriate adjustment in the Exercise Price and the number
      of shares of Common Stock acquirable upon exercise of this Warrant so that
      the rights of the holder shall be neither enhanced nor diminished by such
      event.

            (l) Certain Definitions.

                  (i) "Common Stock Deemed Outstanding" shall mean the number of
            shares of Common Stock actually outstanding (not including shares of
            Common Stock held in the treasury of the Company), plus (x) pursuant
            to Paragraph 4(b)(i) hereof, the maximum total number of shares of
            Common Stock issuable upon the exercise of Options, as of the date
            of such issuance or grant of such Options, if any, and (y) pursuant
            to Paragraph 4(b)(ii) hereof, the maximum total number of shares of
            Common Stock issuable upon conversion or exchange of Convertible
            Securities, as of the date of issuance of such Convertible
            Securities, if any.

                  (ii) "Market Price," as of any date, (i) means the average of
            the last reported sale prices for the shares of Common Stock on the
            OTCBB for the five (5) Trading Days immediately preceding such date
            as reported by Bloomberg, or (ii) if the OTCBB is not the principal
            trading market for the shares of Common Stock, the average of the
            last reported sale prices on the principal trading market for the
            Common Stock during the same period as reported by Bloomberg, or
            (iii) if market value cannot be calculated as of such date on any of
            the foregoing bases, the Market Price shall be the fair market value
            as reasonably determined in good faith by (a) the Board of Directors
            of the Company or, at the option of a majority-in-interest of the
            holders of the outstanding Warrants by (b) an independent investment
            bank of nationally recognized standing in the valuation of
            businesses similar to the business of the corporation. The manner of
            determining the Market Price of the Common Stock set forth in the
            foregoing definition shall apply with respect to any other security
            in respect of which a determination as to market value must be made
            hereunder.

                                       8
<PAGE>

                  (iii) "Common Stock," for purposes of this Paragraph 4,
            includes the Common Stock, par value $.001 per share, and any
            additional class of stock of the Company having no preference as to
            dividends or distributions on liquidation, provided that the shares
            purchasable pursuant to this Warrant shall include only shares of
            Common Stock, par value $.001 per share, in respect of which this
            Warrant is exercisable, or shares resulting from any subdivision or
            combination of such Common Stock, or in the case of any
            reorganization, reclassification, consolidation, merger, or sale of
            the character referred to in Paragraph 4(e) hereof, the stock or
            other securities or property provided for in such Paragraph.

      5. Issue Tax.

      The issuance of certificates for Warrant Shares upon the exercise of this
Warrant shall be made without charge to the holder of this Warrant or such
shares for any issuance tax or other costs in respect thereof, provided that the
Company shall not be required to pay any tax which may be payable in respect of
any transfer involved in the issuance and delivery of any certificate in a name
other than the holder of this Warrant.

      6. No Rights or Liabilities as a Shareholder.

      This Warrant shall not entitle the holder hereof to any voting rights or
other rights as a shareholder of the Company. No provision of this Warrant, in
the absence of affirmative action by the holder hereof to purchase Warrant
Shares, and no mere enumeration herein of the rights or privileges of the holder
hereof, shall give rise to any liability of such holder for the Exercise Price
or as a shareholder of the Company, whether such liability is asserted by the
Company or by creditors of the Company.

      7. Transfer, Exchange, and Replacement of Warrant.

            (a) Restriction on Transfer. This Warrant and the rights granted to
      the holder hereof are transferable, in whole or in part, upon surrender of
      this Warrant, together with a properly executed assignment in the form
      attached hereto, at the office or agency of the Company referred to in
      Paragraph 7(e) below, provided, however, that any transfer or assignment
      shall be subject to the conditions set forth in Paragraph 7(f) hereof and
      to the applicable provisions of the Securities Purchase Agreement. Until
      due presentment for registration of transfer on the books of the Company,
      the Company may treat the registered holder hereof as the owner and holder
      hereof for all purposes, and the Company shall not be affected by any
      notice to the contrary. Notwithstanding anything to the contrary contained
      herein, the registration rights described in Paragraph 8 are assignable
      only in accordance with the provisions of that certain Registration Rights
      Agreement, dated September 12, 2006, by and among the Company and the
      other signatories thereto (the "Registration Rights Agreement").

            (b) Warrant Exchangeable for Different Denominations. This Warrant
      is exchangeable, upon the surrender hereof by the holder hereof at the
      office or agency of the Company referred to in Paragraph 7(e) below, for
      new Warrants of like tenor representing in the aggregate the right to
      purchase the number of shares of Common Stock which may be purchased
      hereunder, each of such new Warrants to represent the right to purchase
      such number of shares as shall be designated by the holder hereof at the
      time of such surrender.

                                       9
<PAGE>

            (c) Replacement of Warrant. Upon receipt of evidence reasonably
      satisfactory to the Company of the loss, theft, destruction, or mutilation
      of this Warrant and, in the case of any such loss, theft, or destruction,
      upon delivery of an indemnity agreement reasonably satisfactory in form
      and amount to the Company, or, in the case of any such mutilation, upon
      surrender and cancellation of this Warrant, the Company, at its expense,
      will execute and deliver, in lieu thereof, a new Warrant of like tenor.

            (d) Cancellation; Payment of Expenses. Upon the surrender of this
      Warrant in connection with any transfer, exchange, or replacement as
      provided in this Paragraph 7, this Warrant shall be promptly canceled by
      the Company. The Company shall pay all taxes (other than securities
      transfer taxes) and all other expenses (other than legal expenses, if any,
      incurred by the holder or transferees) and charges payable in connection
      with the preparation, execution, and delivery of Warrants pursuant to this
      Paragraph 7.

            (e) Register. The Company shall maintain, at its principal executive
      offices (or such other office or agency of the Company as it may designate
      by notice to the holder hereof), a register for this Warrant, in which the
      Company shall record the name and address of the person in whose name this
      Warrant has been issued, as well as the name and address of each
      transferee and each prior owner of this Warrant.

            (f) Exercise or Transfer Without Registration. If, at the time of
      the surrender of this Warrant in connection with any exercise, transfer,
      or exchange of this Warrant, this Warrant (or, in the case of any
      exercise, the Warrant Shares issuable hereunder), shall not be registered
      under the Securities Act of 1933, as amended (the "Securities Act") and
      under applicable state securities or blue sky laws, the Company may
      require, as a condition of allowing such exercise, transfer, or exchange,
      (i) that the holder or transferee of this Warrant, as the case may be,
      furnish to the Company a written opinion of counsel, which opinion and
      counsel are acceptable to the Company, to the effect that such exercise,
      transfer, or exchange may be made without registration under said Act and
      under applicable state securities or blue sky laws, (ii) that the holder
      or transferee execute and deliver to the Company an investment letter in
      form and substance acceptable to the Company and (iii) that the transferee
      be an "accredited investor" as defined in Rule 501(a) promulgated under
      the Securities Act; provided that no such opinion, letter or status as an
      "accredited investor" shall be required in connection with a transfer
      pursuant to Rule 144 under the Securities Act. The first holder of this
      Warrant, by taking and holding the same, represents to the Company that
      such holder is acquiring this Warrant for investment and not with a view
      to the distribution thereof.

      8. Registration Rights.

      The initial holder of this Warrant (and certain assignees thereof) is
entitled to the benefit of such registration rights in respect of the Warrant
Shares as are set forth in Section 2 of the Registration Rights Agreement.

                                       10
<PAGE>

      9. Notices.

      All notices, requests, and other communications required or permitted to
be given or delivered hereunder to the holder of this Warrant shall be in
writing, and shall be personally delivered, or shall be sent by certified or
registered mail or by recognized overnight mail courier, postage prepaid and
addressed, to such holder at the address shown for such holder on the books of
the Company, or at such other address as shall have been furnished to the
Company by notice from such holder. All notices, requests, and other
communications required or permitted to be given or delivered hereunder to the
Company shall be in writing, and shall be personally delivered, or shall be sent
by certified or registered mail or by recognized overnight mail courier, postage
prepaid and addressed, to the office of the Company at 125 Wilbur Place, Suite
120, Bohemia, NY 11716, Attention: Chief Executive Officer, or at such other
address as shall have been furnished to the holder of this Warrant by notice
from the Company. Any such notice, request, or other communication may be sent
by facsimile, but shall in such case be subsequently confirmed by a writing
personally delivered or sent by certified or registered mail or by recognized
overnight mail courier as provided above. All notices, requests, and other
communications shall be deemed to have been given either at the time of the
receipt thereof by the person entitled to receive such notice at the address of
such person for purposes of this Paragraph 9, or, if mailed by registered or
certified mail or with a recognized overnight mail courier upon deposit with the
United States Post Office or such overnight mail courier, if postage is prepaid
and the mailing is properly addressed, as the case may be.

      10. Governing Law.

      THIS WARRANT SHALL BE ENFORCED, GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE
PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO THE PRINCIPLES OF
CONFLICT OF LAWS. THE PARTIES HERETO HEREBY SUBMIT TO THE EXCLUSIVE JURISDICTION
OF THE UNITED STATES FEDERAL COURTS LOCATED IN NEW YORK, NEW YORK WITH RESPECT
TO ANY DISPUTE ARISING UNDER THIS WARRANT, THE AGREEMENTS ENTERED INTO IN
CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. BOTH
PARTIES IRREVOCABLY WAIVE THE DEFENSE OF AN INCONVENIENT FORUM TO THE
MAINTENANCE OF SUCH SUIT OR PROCEEDING. BOTH PARTIES FURTHER AGREE THAT SERVICE
OF PROCESS UPON A PARTY MAILED BY FIRST CLASS MAIL SHALL BE DEEMED IN EVERY
RESPECT EFFECTIVE SERVICE OF PROCESS UPON THE PARTY IN ANY SUCH SUIT OR
PROCEEDING. NOTHING HEREIN SHALL AFFECT EITHER PARTY'S RIGHT TO SERVE PROCESS IN
ANY OTHER MANNER PERMITTED BY LAW. BOTH PARTIES AGREE THAT A FINAL
NON-APPEALABLE JUDGMENT IN ANY SUCH SUIT OR PROCEEDING SHALL BE CONCLUSIVE AND
MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON SUCH JUDGMENT OR IN ANY OTHER
LAWFUL MANNER. THE PARTY WHICH DOES NOT PREVAIL IN ANY DISPUTE ARISING UNDER
THIS WARRANT SHALL BE RESPONSIBLE FOR ALL FEES AND EXPENSES, INCLUDING
ATTORNEYS' FEES, INCURRED BY THE PREVAILING PARTY IN CONNECTION WITH SUCH
DISPUTE.

                                       11
<PAGE>

      11. Miscellaneous.

            (a) Amendments. This Warrant and any provision hereof may only be
      amended by an instrument in writing signed by the Company and the holder
      hereof.

            (b) Descriptive Headings. The descriptive headings of the several
      paragraphs of this Warrant are inserted for purposes of reference only,
      and shall not affect the meaning or construction of any of the provisions
      hereof.

            (c) Cashless Exercise. Notwithstanding anything to the contrary
      contained in this Warrant, if the resale of the Warrant Shares by the
      holder is not then registered pursuant to an effective registration
      statement under the Securities Act, this Warrant may be exercised by
      presentation and surrender of this Warrant to the Company at its principal
      executive offices with a written notice of the holder's intention to
      effect a cashless exercise, including a calculation of the number of
      shares of Common Stock to be issued upon such exercise in accordance with
      the terms hereof (a "Cashless Exercise"). In the event of a Cashless
      Exercise, in lieu of paying the Exercise Price in cash, the holder shall
      surrender this Warrant for that number of shares of Common Stock
      determined by multiplying the number of Warrant Shares to which it would
      otherwise be entitled by a fraction, the numerator of which shall be the
      difference between the then current Market Price per share of the Common
      Stock and the Exercise Price, and the denominator of which shall be the
      then current Market Price per share of Common Stock. For example, if the
      holder is exercising 100,000 Warrants with a per Warrant exercise price of
      $0.75 per share through a cashless exercise when the Common Stock's
      current Market Price per share is $2.00 per share, then upon such Cashless
      Exercise the holder will receive 62,500 shares of Common Stock.

            (d) Remedies. The Company acknowledges that a breach by it of its
      obligations hereunder will cause irreparable harm to the holder, by
      vitiating the intent and purpose of the transaction contemplated hereby.
      Accordingly, the Company acknowledges that the remedy at law for a breach
      of its obligations under this Warrant will be inadequate and agrees, in
      the event of a breach or threatened breach by the Company of the
      provisions of this Warrant, that the holder shall be entitled, in addition
      to all other available remedies at law or in equity, and in addition to
      the penalties assessable herein, to an injunction or injunctions
      restraining, preventing or curing any breach of this Warrant and to
      enforce specifically the terms and provisions thereof, without the
      necessity of showing economic loss and without any bond or other security
      being required.

                 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       12
<PAGE>

            IN WITNESS WHEREOF, the Company has caused this Warrant to be signed
by its duly authorized officer.

                                       ADVANCE BIOPHOTONICS INC.

                                       By: /s/ Denis A. O'Connor
                                           -----------------------
                                           Dennis A. O'Connor
                                           Chief Executive Officer

Dated as of September 12, 2006

                                       13
<PAGE>

                           FORM OF EXERCISE AGREEMENT

                                                      Dated:  ________ __, 200_

To:   ______________________

      The undersigned, pursuant to the provisions set forth in the within
Warrant, hereby agrees to purchase ________ shares of Common Stock covered by
such Warrant, and makes payment herewith in full therefor at the price per share
provided by such Warrant in cash or by certified or official bank check in the
amount of, or, if the resale of such Common Stock by the undersigned is not
currently registered pursuant to an effective registration statement under the
Securities Act of 1933, as amended, by surrender of securities issued by the
Company (including a portion of the Warrant) having a market value (in the case
of a portion of this Warrant, determined in accordance with Section 11(c) of the
Warrant) equal to $_________. Please issue a certificate or certificates for
such shares of Common Stock in the name of and pay any cash for any fractional
share to:

                                          Name:
                                                --------------------------------

                                          Signature:
                                                     ---------------------------
                                          Address:
                                                   -----------------------------

                                                   -----------------------------

                                          Note:       The above signature
                                                      should correspond
                                                      exactly with the name
                                                      on the face of the
                                                      within Warrant, if
                                                      applicable.

and, if said number of shares of Common Stock shall not be all the shares
purchasable under the within Warrant, a new Warrant is to be issued in the name
of said undersigned covering the balance of the shares purchasable thereunder
less any fraction of a share paid in cash.

<PAGE>

                               FORM OF ASSIGNMENT

      FOR VALUE RECEIVED, the undersigned hereby sells, assigns, and transfers
all the rights of the undersigned under the within Warrant, with respect to the
number of shares of Common Stock covered thereby set forth hereinbelow, to:

Name of Assignee                     Address                        No of Shares
----------------                     -------                        ------------

, and hereby irrevocably constitutes and appoints ______________________________
as agent and attorney-in-fact to transfer said Warrant on the books of the
within-named corporation, with full power of substitution in the premises.

Dated:      ________ __, 200_

In the presence of:
                                          --------------------------------------

                                    Name:
                                          --------------------------------------

                                    Signature:
                                               ---------------------------------

                                    Title of Signing Officer or Agent (if any):

                                                ------------------------------
                                    Address:
                                                ------------------------------

                                                ------------------------------

                                          Note: The above signature should
                                                correspond exactly with the
                                                name on the face of the
                                                within Warrant, if applicable.REGISTRATION RIGHTS AGREEMENT

      REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of September
12, 2006, by and among Advanced Biophotonics Inc., a Delaware corporation with
its headquarters located at 125 Wilbur Place, Suite 120, Bohemia, NY 11716 (the
"Company"), and each of the undersigned (together with their respective
affiliates and any assignee or transferee of all of their respective rights
hereunder, the "Initial Investors").

      WHEREAS:

      A. In connection with the Securities Purchase Agreement by and among the
parties hereto of even date herewith (the "Securities Purchase Agreement"), the
Company has agreed, upon the terms and subject to the conditions contained
therein, to issue and sell to the Initial Investors (i) secured convertible
notes in the aggregate principal amount of up to Seven Hundred and Seventy-Five
Thousand Dollars ($775,000) (the "Notes") that are convertible into shares of
the Company's common stock (the "Common Stock"), upon the terms and subject to
the limitations and conditions set forth in such Notes and (ii) warrants (the
"Warrants") to acquire an aggregate of 20,000,000 shares of Common Stock, upon
the terms and conditions and subject to the limitations and conditions set forth
in the Warrants; and

      B. To induce the Initial Investors to execute and deliver the Securities
Purchase Agreement, the Company has agreed to provide certain registration
rights under the Securities Act of 1933, as amended, and the rules and
regulations thereunder, or any similar successor statute (collectively, the
"1933 Act"), and applicable state securities laws;

      NOW, THEREFORE, in consideration of the premises and the mutual covenants
contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and each of the
Initial Investors hereby agree as follows:

      1. DEFINITIONS.

            a. As used in this Agreement, the following terms shall have the
      following meanings:

                  (i) "Investors" means the Initial Investors and any transferee
            or assignee who agrees to become bound by the provisions of this
            Agreement in accordance with Section 9 hereof.

                  (ii) "register," "registered," and "registration" refer to a
            registration effected by preparing and filing a Registration
            Statement or Statements in compliance with the 1933 Act and pursuant
            to Rule 415 under the 1933 Act or any successor rule providing for
            offering securities on a continuous basis ("Rule 415"), and the
            declaration or ordering of effectiveness of such Registration
            Statement by the United States Securities and Exchange Commission
            (the "SEC").

                  (iii) "Registrable Securities" means the Conversion Shares
            issued or issuable upon conversion or otherwise pursuant to the
            Notes and Additional Notes (as defined in the Securities Purchase
            Agreement) including, without limitation, Damages Shares (as defined
            in the Notes) issued or issuable pursuant to the Notes, shares of
            Common Stock issued or issuable in payment of the Standard
            Liquidated Damages Amount (as defined in the Securities Purchase
            Agreement), shares issued or issuable in respect of interest or in
            redemption of the Notes in accordance with the terms thereof) and
            Warrant Shares issuable, upon exercise or otherwise pursuant to the
            Warrants and Additional Warrants (as defined in the Securities
            Purchase Agreement), and any shares of capital stock issued or
            issuable as a dividend on or in exchange for or otherwise with
            respect to any of the foregoing.

<PAGE>

                  (iv) "Registration Statement" means a registration statement
            of the Company under the 1933 Act.

            b. Capitalized terms used herein and not otherwise defined herein
      shall have the respective meanings set forth in the Securities Purchase
      Agreement or the Convertible Note.

      2. REGISTRATION.

            a. Mandatory Registration. The Company shall prepare, and, on or
      prior to thirty (30) days from the date of receipt of written demand of
      the Investors (the "Filing Date"), file with the SEC a Registration
      Statement on Form S-3 (or, if Form S-3 is not then available, on such form
      of Registration Statement as is then available to effect a registration of
      the Registrable Securities, subject to the consent of the Initial
      Investors, which consent will not be unreasonably withheld) covering the
      resale of the Registrable Securities underlying the Notes and Warrants
      issued or issuable pursuant to the Securities Purchase Agreement, which
      Registration Statement, to the extent allowable under the 1933 Act and the
      rules and regulations promulgated thereunder (including Rule 416), shall
      state that such Registration Statement also covers such indeterminate
      number of additional shares of Common Stock as may become issuable upon
      conversion of or otherwise pursuant to the Notes and exercise of the
      Warrants to prevent dilution resulting from stock splits, stock dividends
      or similar transactions. The number of shares of Common Stock initially
      included in such Registration Statement shall be no less than an amount
      equal to the sum of the number of Conversion Shares that are then issuable
      upon conversion of the Notes (based on the Variable Conversion Price as
      would then be in effect and assuming the Variable Conversion Price is the
      Conversion Price at such time), and the number of Warrant Shares that are
      then issuable upon exercise of the Warrants, without regard to any
      limitation on the Investor's ability to convert the Notes or exercise the
      Warrants. The Company acknowledges that the number of shares initially
      included in the Registration Statement represents a good faith estimate of
      the maximum number of shares issuable upon conversion of the Notes and
      upon exercise of the Warrants.

            b. Underwritten Offering. If any offering pursuant to a Registration
      Statement pursuant to Section 2(a) hereof involves an underwritten
      offering, the Investors who hold a majority in interest of the Registrable
      Securities subject to such underwritten offering, with the consent of a
      majority-in-interest of the Initial Investors, shall have the right to
      select one legal counsel and an investment banker or bankers and manager
      or managers to administer the offering, which investment banker or bankers
      or manager or managers shall be reasonably satisfactory to the Company.

                                       2
<PAGE>

            c. Payments by the Company. The Company shall use its best efforts
      to obtain effectiveness of the Registration Statement as soon as
      practicable. If (i) the Registration Statement(s) covering the Registrable
      Securities required to be filed by the Company pursuant to Section 2(a)
      hereof is not filed by the Filing Date or declared effective by the SEC on
      or prior to one hundred and twenty (120) days from the date of Closing (as
      defined in the Securities Purchase Agreement), or (ii) after the
      Registration Statement has been declared effective by the SEC, sales of
      all of the Registrable Securities cannot be made pursuant to the
      Registration Statement, or (iii) the Common Stock is not listed or
      included for quotation on the Nasdaq National Market ("Nasdaq"), the
      Nasdaq SmallCap Market ("Nasdaq SmallCap"), the New York Stock Exchange
      (the "NYSE") or the American Stock Exchange (the "AMEX") after being so
      listed or included for quotation after the date hereof, or (iv) the Common
      Stock ceases to be traded on the Over-the-Counter Bulletin Board (the
      "OTCBB") or any equivalent replacement exchange prior to being listed or
      included for quotation on one of the aforementioned markets, then the
      Company will make payments to the Investors in such amounts and at such
      times as shall be determined pursuant to this Section 2(c) as partial
      relief for the damages to the Investors by reason of any such delay in or
      reduction of their ability to sell the Registrable Securities (which
      remedy shall not be exclusive of any other remedies available at law or in
      equity). The Company shall pay to each holder of the Notes or Registrable
      Securities an amount equal to the then outstanding principal amount of the
      Notes (and, in the case of holders of Registrable Securities, the
      principal amount of Notes from which such Registrable Securities were
      converted) ("Outstanding Principal Amount"), multiplied by the Applicable
      Percentage (as defined below) times the sum of: (i) the number of months
      (prorated for partial months) after the Filing Date or the end of the
      aforementioned one hundred and twenty (120) day period and prior to the
      date the Registration Statement is declared effective by the SEC,
      provided, however, that there shall be excluded from such period any
      delays which are solely attributable to changes required by the Investors
      in the Registration Statement with respect to information relating to the
      Investors, including, without limitation, changes to the plan of
      distribution, or to the failure of the Investors to conduct their review
      of the Registration Statement pursuant to Section 3(h) below in a
      reasonably prompt manner; (ii) the number of months (prorated for partial
      months) that sales of all of the Registrable Securities cannot be made
      pursuant to the Registration Statement after the Registration Statement
      has been declared effective (including, without limitation, when sales
      cannot be made by reason of the Company's failure to properly supplement
      or amend the prospectus included therein in accordance with the terms of
      this Agreement, but excluding any days during an Allowed Delay (as defined
      in Section 3(f)); and (iii) the number of months (prorated for partial
      months) that the Common Stock is not listed or included for quotation on
      the OTCBB, Nasdaq, Nasdaq SmallCap, NYSE or AMEX or that trading thereon
      is halted after the Registration Statement has been declared effective.
      The term "Applicable Percentage" means two hundredths (.02). (For example,
      if the Registration Statement becomes effective one (1) month after the
      end of such one hundred and twenty (120) day period, the Company would pay
      $5,000 for each $250,000 of Outstanding Principal Amount. If thereafter,
      sales could not be made pursuant to the Registration Statement for an
      additional period of one (1) month, the Company would pay an additional
      $5,000 for each $250,000 of Outstanding Principal Amount.) Such amounts
      shall be paid in cash or, at the Company's option, in shares of Common
      Stock priced at the Conversion Price (as defined in the Notes) on such
      payment date.

                                       3
<PAGE>

            d. Piggy-Back Registrations. Subject to the last sentence of this
      Section 2(d), if at any time prior to the expiration of the Registration
      Period (as hereinafter defined) the Company shall determine to file with
      the SEC a Registration Statement relating to an offering for its own
      account or the account of others under the 1933 Act of any of its equity
      securities (other than on Form S-4 or Form S-8 or their then equivalents
      relating to equity securities to be issued solely in connection with any
      acquisition of any entity or business or equity securities issuable in
      connection with stock option or other bona fide, employee benefit plans),
      the Company shall send to each Investor who is entitled to registration
      rights under this Section 2(d) written notice of such determination and,
      if within fifteen (15) days after the effective date of such notice, such
      Investor shall so request in writing, the Company shall include in such
      Registration Statement all or any part of the Registrable Securities such
      Investor requests to be registered, except that if, in connection with any
      underwritten public offering for the account of the Company the managing
      underwriter(s) thereof shall impose a limitation on the number of shares
      of Common Stock which may be included in the Registration Statement
      because, in such underwriter(s)' judgment, marketing or other factors
      dictate such limitation is necessary to facilitate public distribution,
      then the Company shall be obligated to include in such Registration
      Statement only such limited portion of the Registrable Securities with
      respect to which such Investor has requested inclusion hereunder as the
      underwriter shall permit. Any exclusion of Registrable Securities shall be
      made pro rata among the Investors seeking to include Registrable
      Securities in proportion to the number of Registrable Securities sought to
      be included by such Investors; provided, however, that the Company shall
      not exclude any Registrable Securities unless the Company has first
      excluded all outstanding securities, the holders of which are not entitled
      to inclusion of such securities in such Registration Statement or are not
      entitled to pro rata inclusion with the Registrable Securities; and
      provided, further, however, that, after giving effect to the immediately
      preceding proviso, any exclusion of Registrable Securities shall be made
      pro rata with holders of other securities having the right to include such
      securities in the Registration Statement other than holders of securities
      entitled to inclusion of their securities in such Registration Statement
      by reason of demand registration rights. No right to registration of
      Registrable Securities under this Section 2(d) shall be construed to limit
      any registration required under Section 2(a) hereof. If an offering in
      connection with which an Investor is entitled to registration under this
      Section 2(d) is an underwritten offering, then each Investor whose
      Registrable Securities are included in such Registration Statement shall,
      unless otherwise agreed by the Company, offer and sell such Registrable
      Securities in an underwritten offering using the same underwriter or
      underwriters and, subject to the provisions of this Agreement, on the same
      terms and conditions as other shares of Common Stock included in such
      underwritten offering. Notwithstanding anything to the contrary set forth
      herein, the registration rights of the Investors pursuant to this Section
      2(d) shall only be available in the event the Company fails to timely
      file, obtain effectiveness or maintain effectiveness of any Registration
      Statement to be filed pursuant to Section 2(a) in accordance with the
      terms of this Agreement.

            e. Eligibility for Form S-3, SB-2 or S-1; Conversion to Form S-3.
      The Company represents and warrants that it meets the requirements for the
      use of Form S-3, SB-2 or S-1 for registration of the sale by the Initial
      Investors and any other Investors of the Registrable Securities. The
      Company agrees to file all reports required to be filed by the Company
      with the SEC in a timely manner so as to remain eligible or become
      eligible, as the case may be, and thereafter to maintain its eligibility,
      for the use of Form SB-2. If the Company is not currently eligible to use
      Form S-3, not later than five (5) business days after the Company first
      meets the registration eligibility and transaction requirements for the
      use of Form S-3 (or any successor form) for registration of the offer and
      sale by the Initial Investors and any other Investors of Registrable
      Securities, the Company shall file a Registration Statement on Form S-3
      (or such successor form) with respect to the Registrable Securities
      covered by the Registration Statement on Form SB-2 or Form S-1, whichever
      is applicable, filed pursuant to Section 2(a) (and include in such
      Registration Statement on Form S-3 the information required by Rule 429
      under the 1933 Act) or convert the Registration Statement on Form SB-2 or
      Form S-1, whichever is applicable, filed pursuant to Section 2(a) to a
      Form S-3 pursuant to Rule 429 under the 1933 Act and cause such
      Registration Statement (or such amendment) to be declared effective no
      later than sixty (60) days after filing. In the event of a breach by the
      Company of the provisions of this Section 2(e), the Company will be
      required to make payments pursuant to Section 2(c) hereof.

                                       4
<PAGE>

      3. OBLIGATIONS OF THE COMPANY.

      In connection with the registration of the Registrable Securities, the
Company shall have the following obligations:

            a. The Company shall prepare promptly, and file with the SEC not
      later than the Filing Date, a Registration Statement with respect to the
      number of Registrable Securities provided in Section 2(a), and thereafter
      use its best efforts to cause such Registration Statement relating to
      Registrable Securities to become effective as soon as possible after such
      filing but in no event later than one hundred and twenty (120) days from
      the date of Closing), and keep the Registration Statement effective
      pursuant to Rule 415 at all times until such date as is the earlier of (i)
      the date on which all of the Registrable Securities have been sold and
      (ii) the date on which the Registrable Securities (in the opinion of
      counsel to the Initial Investors) may be immediately sold to the public
      without registration or restriction (including, without limitation, as to
      volume by each holder thereof) under the 1933 Act (the "Registration
      Period"), which Registration Statement (including any amendments or
      supplements thereto and prospectuses contained therein) shall not contain
      any untrue statement of a material fact or omit to state a material fact
      required to be stated therein, or necessary to make the statements therein
      not misleading.

            b. The Company shall prepare and file with the SEC such amendments
      (including post-effective amendments) and supplements to the Registration
      Statements and the prospectus used in connection with the Registration
      Statements as may be necessary to keep the Registration Statements
      effective at all times during the Registration Period, and, during such
      period, comply with the provisions of the 1933 Act with respect to the
      disposition of all Registrable Securities of the Company covered by the
      Registration Statements until such time as all of such Registrable
      Securities have been disposed of in accordance with the intended methods
      of disposition by the seller or sellers thereof as set forth in the
      Registration Statements. In the event the number of shares available under
      a Registration Statement filed pursuant to this Agreement is insufficient
      to cover all of the Registrable Securities issued or issuable upon
      conversion of the Notes and exercise of the Warrants, the Company shall
      amend the Registration Statement, or file a new Registration Statement (on
      the short form available therefor, if applicable), or both, so as to cover
      all of the Registrable Securities, in each case, as soon as practicable,
      but in any event within fifteen (15) days after the necessity therefor
      arises (based on the market price of the Common Stock and other relevant
      factors on which the Company reasonably elects to rely). The Company shall
      use its best efforts to cause such amendment and/or new Registration
      Statement to become effective as soon as practicable following the filing
      thereof, but in any event within thirty (30) days after the date on which
      the Company reasonably first determines (or reasonably should have
      determined) the need therefor. The provisions of Section 2(c) above shall
      be applicable with respect to such obligation, with the one hundred and
      twenty (120) days running from the day the Company reasonably first
      determines (or reasonably should have determined) the need therefor.

                                       5
<PAGE>

            c. The Company shall furnish to each Investor whose Registrable
      Securities are included in a Registration Statement and its legal counsel
      (i) promptly (but in no event more than two (2) business days) after the
      same is prepared and publicly distributed, filed with the SEC, or received
      by the Company, one copy of each Registration Statement and any amendment
      thereto, each preliminary prospectus and prospectus and each amendment or
      supplement thereto, and, in the case of the Registration Statement
      referred to in Section 2(a), each letter written by or on behalf of the
      Company to the SEC or the staff of the SEC, and each item of
      correspondence from the SEC or the staff of the SEC, in each case relating
      to such Registration Statement (other than any portion of any thereof
      which contains information for which the Company has sought confidential
      treatment), and (ii) promptly (but in no event more than two (2) business
      days) after the Registration Statement is declared effective by the SEC,
      such number of copies of a prospectus, including a preliminary prospectus,
      and all amendments and supplements thereto and such other documents as
      such Investor may reasonably request in order to facilitate the
      disposition of the Registrable Securities owned by such Investor. The
      Company will immediately notify each Investor by facsimile of the
      effectiveness of each Registration Statement or any post-effective
      amendment. The Company will promptly respond to any and all comments
      received from the SEC (which comments shall promptly be made available to
      the Investors upon request), with a view towards causing each Registration
      Statement or any amendment thereto to be declared effective by the SEC as
      soon as practicable, shall promptly file an acceleration request as soon
      as practicable (but in no event more than two (2) business days) following
      the resolution or clearance of all SEC comments or, if applicable,
      following notification by the SEC that any such Registration Statement or
      any amendment thereto will not be subject to review and shall, if required
      by SEC Rules, promptly file with the SEC a final prospectus as soon as
      practicable (but in no event more than two (2) business days) following
      receipt by the Company from the SEC of an order declaring the Registration
      Statement effective. In the event of a breach by the Company of the
      provisions of this Section 3(c), the Company will be required to make
      payments pursuant to Section 2(c) hereof.

            d. The Company shall use reasonable efforts to (i) register and
      qualify the Registrable Securities covered by the Registration Statements
      under such other securities or "blue sky" laws of such jurisdictions in
      the United States as the Investors who hold a majority in interest of the
      Registrable Securities being offered reasonably request, (ii) prepare and
      file in those jurisdictions such amendments (including post-effective
      amendments) and supplements to such registrations and qualifications as
      may be necessary to maintain the effectiveness thereof during the
      Registration Period, (iii) take such other actions as may be necessary to
      maintain such registrations and qualifications in effect at all times
      during the Registration Period, and (iv) take all other actions reasonably
      necessary or advisable to qualify the Registrable Securities for sale in
      such jurisdictions; provided, however, that the Company shall not be
      required in connection therewith or as a condition thereto to (a) qualify
      to do business in any jurisdiction where it would not otherwise be
      required to qualify but for this Section 3(d), (b) subject itself to
      general taxation in any such jurisdiction, (c) file a general consent to
      service of process in any such jurisdiction, (d) provide any undertakings
      that cause the Company undue expense or burden, or (e) make any change in
      its charter or bylaws, which in each case the Board of Directors of the
      Company determines to be contrary to the best interests of the Company and
      its shareholders.

                                       6
<PAGE>

            e. In the event Investors who hold a majority-in-interest of the
      Registrable Securities being offered in the offering (with the approval of
      a majority-in-interest of the Initial Investors) select underwriters for
      the offering, the Company shall enter into and perform its obligations
      under an underwriting agreement, in usual and customary form, including,
      without limitation, customary indemnification and contribution
      obligations, with the underwriters of such offering.

            f. As promptly as practicable after becoming aware of such event,
      the Company shall notify each Investor of the happening of any event, of
      which the Company has knowledge, as a result of which the prospectus
      included in any Registration Statement, as then in effect, includes an
      untrue statement of a material fact or omission to state a material fact
      required to be stated therein or necessary to make the statements therein
      not misleading, and use its best efforts promptly to prepare a supplement
      or amendment to any Registration Statement to correct such untrue
      statement or omission, and deliver such number of copies of such
      supplement or amendment to each Investor as such Investor may reasonably
      request; provided that, for not more than ten (10) consecutive trading
      days (or a total of not more than twenty (20) trading days in any twelve
      (12) month period), the Company may delay the disclosure of material
      non-public information concerning the Company (as well as prospectus or
      Registration Statement updating) the disclosure of which at the time is
      not, in the good faith opinion of the Company, in the best interests of
      the Company (an "Allowed Delay"); provided, further, that the Company
      shall promptly (i) notify the Investors in writing of the existence of
      (but in no event, without the prior written consent of an Investor, shall
      the Company disclose to such investor any of the facts or circumstances
      regarding) material non-public information giving rise to an Allowed Delay
      and (ii) advise the Investors in writing to cease all sales under such
      Registration Statement until the end of the Allowed Delay. Upon expiration
      of the Allowed Delay, the Company shall again be bound by the first
      sentence of this Section 3(f) with respect to the information giving rise
      thereto.

            g. The Company shall use its best efforts to prevent the issuance of
      any stop order or other suspension of effectiveness of any Registration
      Statement, and, if such an order is issued, to obtain the withdrawal of
      such order at the earliest possible moment and to notify each Investor who
      holds Registrable Securities being sold (or, in the event of an
      underwritten offering, the managing underwriters) of the issuance of such
      order and the resolution thereof.

            h. The Company shall permit a single firm of counsel designated by
      the Initial Investors to review such Registration Statement and all
      amendments and supplements thereto (as well as all requests for
      acceleration or effectiveness thereof) a reasonable period of time prior
      to their filing with the SEC, and not file any document in a form to which
      such counsel reasonably objects and will not request acceleration of such
      Registration Statement without prior notice to such counsel. The sections
      of such Registration Statement covering information with respect to the
      Investors, the Investor's beneficial ownership of securities of the
      Company or the Investors intended method of disposition of Registrable
      Securities shall conform to the information provided to the Company by
      each of the Investors.

                                       7
<PAGE>

            i. The Company shall make generally available to its security
      holders as soon as practicable, but not later than one hundred and twenty
      (120) days after the close of the period covered thereby, an earnings
      statement (in form complying with the provisions of Rule 158 under the
      1933 Act) covering a twelve-month period beginning not later than the
      first day of the Company's fiscal quarter next following the effective
      date of the Registration Statement.

            j. At the request of any Investor, the Company shall furnish, on the
      date that Registrable Securities are delivered to an underwriter, if any,
      for sale in connection with any Registration Statement or, if such
      securities are not being sold by an underwriter, on the date of
      effectiveness thereof (i) an opinion, dated as of such date, from counsel
      representing the Company for purposes of such Registration Statement, in
      form, scope and substance as is customarily given in an underwritten
      public offering, addressed to the underwriters, if any, and the Investors
      and (ii) a letter, dated such date, from the Company's independent
      certified public accountants in form and substance as is customarily given
      by independent certified public accountants to underwriters in an
      underwritten public offering, addressed to the underwriters, if any, and
      the Investors.

            k. The Company shall make available for inspection by (i) any
      Investor, (ii) any underwriter participating in any disposition pursuant
      to a Registration Statement, (iii) one firm of attorneys and one firm of
      accountants or other agents retained by the Initial Investors, (iv) one
      firm of attorneys and one firm of accountants or other agents retained by
      all other Investors, and (v) one firm of attorneys retained by all such
      underwriters (collectively, the "Inspectors") all pertinent financial and
      other records, and pertinent corporate documents and properties of the
      Company, including without limitation, records of conversions by other
      holders of convertible securities issued by the Company and the issuance
      of stock to such holders pursuant to the conversions (collectively, the
      "Records"), as shall be reasonably deemed necessary by each Inspector to
      enable each Inspector to exercise its due diligence responsibility, and
      cause the Company's officers, directors and employees to supply all
      information which any Inspector may reasonably request for purposes of
      such due diligence; provided, however, that each Inspector shall hold in
      confidence and shall not make any disclosure (except to an Investor) of
      any Record or other information which the Company determines in good faith
      to be confidential, and of which determination the Inspectors are so
      notified, unless (a) the disclosure of such Records is necessary to avoid
      or correct a misstatement or omission in any Registration Statement, (b)
      the release of such Records is ordered pursuant to a subpoena or other
      order from a court or government body of competent jurisdiction, or (c)
      the information in such Records has been made generally available to the
      public other than by disclosure in violation of this or any other
      agreement. The Company shall not be required to disclose any confidential
      information in such Records to any Inspector until and unless such
      Inspector shall have entered into confidentiality agreements (in form and
      substance satisfactory to the Company) with the Company with respect
      thereto, substantially in the form of this Section 3(k). Each Investor
      agrees that it shall, upon learning that disclosure of such Records is
      sought in or by a court or governmental body of competent jurisdiction or
      through other means, give prompt notice to the Company and allow the
      Company, at its expense, to undertake appropriate action to prevent
      disclosure of, or to obtain a protective order for, the Records deemed
      confidential. Nothing herein (or in any other confidentiality agreement
      between the Company and any Investor) shall be deemed to limit the
      Investor's ability to sell Registrable Securities in a manner which is
      otherwise consistent with applicable laws and regulations.

                                       8
<PAGE>

            l. The Company shall hold in confidence and not make any disclosure
      of information concerning an Investor provided to the Company unless (i)
      disclosure of such information is necessary to comply with federal or
      state securities laws, (ii) the disclosure of such information is
      necessary to avoid or correct a misstatement or omission in any
      Registration Statement, (iii) the release of such information is ordered
      pursuant to a subpoena or other order from a court or governmental body of
      competent jurisdiction, or (iv) such information has been made generally
      available to the public other than by disclosure in violation of this or
      any other agreement. The Company agrees that it shall, upon learning that
      disclosure of such information concerning an Investor is sought in or by a
      court or governmental body of competent jurisdiction or through other
      means, give prompt notice to such Investor prior to making such
      disclosure, and allow the Investor, at its expense, to undertake
      appropriate action to prevent disclosure of, or to obtain a protective
      order for, such information.

            m. The Company shall (i) cause all the Registrable Securities
      covered by the Registration Statement to be listed on each national
      securities exchange on which securities of the same class or series issued
      by the Company are then listed, if any, if the listing of such Registrable
      Securities is then permitted under the rules of such exchange, or (ii) to
      the extent the securities of the same class or series are not then listed
      on a national securities exchange, secure the designation and quotation,
      of all the Registrable Securities covered by the Registration Statement on
      Nasdaq or, if not eligible for Nasdaq, on Nasdaq SmallCap or, if not
      eligible for Nasdaq or Nasdaq SmallCap, on the OTCBB and, without limiting
      the generality of the foregoing, to arrange for at least two market makers
      to register with the National Association of Securities Dealers, Inc.
      ("NASD") as such with respect to such Registrable Securities.

            n. The Company shall provide a transfer agent and registrar, which
      may be a single entity, for the Registrable Securities not later than the
      effective date of the Registration Statement.

            o. The Company shall cooperate with the Investors who hold
      Registrable Securities being offered and the managing underwriter or
      underwriters, if any, to facilitate the timely preparation and delivery of
      certificates (not bearing any restrictive legends) representing
      Registrable Securities to be offered pursuant to a Registration Statement
      and enable such certificates to be in such denominations or amounts, as
      the case may be, as the managing underwriter or underwriters, if any, or
      the Investors may reasonably request and registered in such names as the
      managing underwriter or underwriters, if any, or the Investors may
      request, and, within three (3) business days after a Registration
      Statement which includes Registrable Securities is ordered effective by
      the SEC, the Company shall deliver, and shall cause legal counsel selected
      by the Company to deliver, to the transfer agent for the Registrable
      Securities (with copies to the Investors whose Registrable Securities are
      included in such Registration Statement) an instruction in the form
      attached hereto as Exhibit 1 and an opinion of such counsel in the form
      attached hereto as Exhibit 2.

                                       9
<PAGE>

            p. At the request of the holders of a majority-in-interest of the
      Registrable Securities, the Company shall prepare and file with the SEC
      such amendments (including post-effective amendments) and supplements to a
      Registration Statement and any prospectus used in connection with the
      Registration Statement as may be necessary in order to change the plan of
      distribution set forth in such Registration Statement.

            q. From and after the date of this Agreement, the Company shall not,
      and shall not agree to, allow the holders of any securities of the Company
      to include any of their securities, in excess of 250,000 shares of Common
      Stock, in any Registration Statement under Section 2(a) hereof or any
      amendment or supplement thereto under Section 3(b) hereof without the
      consent of the holders of a majority-in-interest of the Registrable
      Securities.

            r. The Company shall take all other reasonable actions necessary to
      expedite and facilitate disposition by the Investors of Registrable
      Securities pursuant to a Registration Statement.

      4. OBLIGATIONS OF THE INVESTORS.

      In connection with the registration of the Registrable Securities, the
Investors shall have the following obligations:

            a. It shall be a condition precedent to the obligations of the
      Company to complete the registration pursuant to this Agreement with
      respect to the Registrable Securities of a particular Investor that such
      Investor shall furnish to the Company such information regarding itself,
      the Registrable Securities held by it and the intended method of
      disposition of the Registrable Securities held by it as shall be
      reasonably required to effect the registration of such Registrable
      Securities and shall execute such documents in connection with such
      registration as the Company may reasonably request. At least three (3)
      business days prior to the first anticipated filing date of the
      Registration Statement, the Company shall notify each Investor of the
      information the Company requires from each such Investor.

            b. Each Investor, by such Investor's acceptance of the Registrable
      Securities, agrees to cooperate with the Company as reasonably requested
      by the Company in connection with the preparation and filing of the
      Registration Statements hereunder, unless such Investor has notified the
      Company in writing of such Investor's election to exclude all of such
      Investor's Registrable Securities from the Registration Statements.

            c. In the event Investors holding a majority-in-interest of the
      Registrable Securities being registered (with the approval of the Initial
      Investors) determine to engage the services of an underwriter, each
      Investor agrees to enter into and perform such Investor's obligations
      under an underwriting agreement, in usual and customary form, including,
      without limitation, customary indemnification and contribution
      obligations, with the managing underwriter of such offering and take such
      other actions as are reasonably required in order to expedite or
      facilitate the disposition of the Registrable Securities, unless such
      Investor has notified the Company in writing of such Investor's election
      to exclude all of such Investor's Registrable Securities from such
      Registration Statement.

                                       10
<PAGE>

            d. Each Investor agrees that, upon receipt of any notice from the
      Company of the happening of any event of the kind described in Section
      3(f) or 3(g), such Investor will immediately discontinue disposition of
      Registrable Securities pursuant to the Registration Statement covering
      such Registrable Securities until such Investor's receipt of the copies of
      the supplemented or amended prospectus contemplated by Section 3(f) or
      3(g) and, if so directed by the Company, such Investor shall deliver to
      the Company (at the expense of the Company) or destroy (and deliver to the
      Company a certificate of destruction) all copies in such Investor's
      possession, of the prospectus covering such Registrable Securities current
      at the time of receipt of such notice.

            e. No Investor may participate in any underwritten registration
      hereunder unless such Investor (i) agrees to sell such Investor's
      Registrable Securities on the basis provided in any underwriting
      arrangements in usual and customary form entered into by the Company, (ii)
      completes and executes all questionnaires, powers of attorney,
      indemnities, underwriting agreements and other documents reasonably
      required under the terms of such underwriting arrangements, and (iii)
      agrees to pay its pro rata share of all underwriting discounts and
      commissions and any expenses in excess of those payable by the Company
      pursuant to Section 5 below.

      5. EXPENSES OF REGISTRATION.

      All reasonable expenses, other than underwriting discounts and
commissions, incurred in connection with registrations, filings or
qualifications pursuant to Sections 2 and 3, including, without limitation, all
registration, listing and qualification fees, printers and accounting fees, the
fees and disbursements of counsel for the Company, and the reasonable fees and
disbursements of one counsel selected by the Initial Investors pursuant to
Sections 2(b) and 3(h) hereof shall be borne by the Company and shall be
included in the fees paid to counsel under the Securities Purchase Agreement for
purposes of counsel selected by the Initial Investors.

                                       11
<PAGE>

      6. INDEMNIFICATION.

      In the event any Registrable Securities are included in a Registration
Statement under this Agreement:

            a. To the extent permitted by law, the Company will indemnify, hold
      harmless and defend (i) each Investor who holds such Registrable
      Securities, (ii) the directors, officers, partners, employees, agents and
      each person who controls any Investor within the meaning of the 1933 Act
      or the Securities Exchange Act of 1934, as amended (the "1934 Act"), if
      any, (iii) any underwriter (as defined in the 1933 Act) for the Investors,
      and (iv) the directors, officers, partners, employees and each person who
      controls any such underwriter within the meaning of the 1933 Act or the
      1934 Act, if any (each, an "Indemnified Person"), against any joint or
      several losses, claims, damages, liabilities or expenses (collectively,
      together with actions, proceedings or inquiries by any regulatory or
      self-regulatory organization, whether commenced or threatened, in respect
      thereof, "Claims") to which any of them may become subject insofar as such
      Claims arise out of or are based upon: (i) any untrue statement or alleged
      untrue statement of a material fact in a Registration Statement or the
      omission or alleged omission to state therein a material fact required to
      be stated or necessary to make the statements therein not misleading; (ii)
      any untrue statement or alleged untrue statement of a material fact
      contained in any preliminary prospectus if used prior to the effective
      date of such Registration Statement, or contained in the final prospectus
      (as amended or supplemented, if the Company files any amendment thereof or
      supplement thereto with the SEC) or the omission or alleged omission to
      state therein any material fact necessary to make the statements made
      therein, in light of the circumstances under which the statements therein
      were made, not misleading; or (iii) any violation or alleged violation by
      the Company of the 1933 Act, the 1934 Act, any other law, including,
      without limitation, any state securities law, or any rule or regulation
      thereunder relating to the offer or sale of the Registrable Securities
      (the matters in the foregoing clauses (i) through (iii) being,
      collectively, "Violations"). Subject to the restrictions set forth in
      Section 6(c) with respect to the number of legal counsel, the Company
      shall reimburse the Indemnified Person, promptly as such expenses are
      incurred and are due and payable, for any reasonable legal fees or other
      reasonable expenses incurred by them in connection with investigating or
      defending any such Claim. Notwithstanding anything to the contrary
      contained herein, the indemnification agreement contained in this Section
      6(a): (i) shall not apply to a Claim arising out of or based upon a
      Violation which occurs in reliance upon and in conformity with information
      furnished in writing to the Company by any Indemnified Person or
      underwriter for such Indemnified Person expressly for use in connection
      with the preparation of such Registration Statement or any such amendment
      thereof or supplement thereto, if such prospectus was timely made
      available by the Company pursuant to Section 3(c) hereof; (ii) shall not
      apply to amounts paid in settlement of any Claim if such settlement is
      effected without the prior written consent of the Company, which consent
      shall not be unreasonably withheld; and (iii) with respect to any
      preliminary prospectus, shall not inure to the benefit of any Indemnified
      Person if the untrue statement or omission of material fact contained in
      the preliminary prospectus was corrected on a timely basis in the
      prospectus, as then amended or supplemented, such corrected prospectus was
      timely made available by the Company pursuant to Section 3(c) hereof, and
      the Indemnified Person was promptly advised in writing not to use the
      incorrect prospectus prior to the use giving rise to a Violation and such
      Indemnified Person, notwithstanding such advice, used it. Such indemnity
      shall remain in full force and effect regardless of any investigation made
      by or on behalf of the Indemnified Person and shall survive the transfer
      of the Registrable Securities by the Investors pursuant to Section 9.

            b. In connection with any Registration Statement in which an
      Investor is participating, each such Investor agrees severally and not
      jointly to indemnify, hold harmless and defend, to the same extent and in
      the same manner set forth in Section 6(a), the Company, each of its
      directors, each of its officers who signs the Registration Statement, each
      person, if any, who controls the Company within the meaning of the 1933
      Act or the 1934 Act, any underwriter and any other shareholder selling
      securities pursuant to the Registration Statement or any of its directors
      or officers or any person who controls such shareholder or underwriter
      within the meaning of the 1933 Act or the 1934 Act (collectively and
      together with an Indemnified Person, an "Indemnified Party"), against any
      Claim to which any of them may become subject, under the 1933 Act, the
      1934 Act or otherwise, insofar as such Claim arises out of or is based
      upon any Violation by such Investor, in each case to the extent (and only
      to the extent) that such Violation occurs in reliance upon and in
      conformity with written information furnished to the Company by such
      Investor expressly for use in connection with such Registration Statement;
      and subject to Section 6(c) such Investor will reimburse any legal or
      other expenses (promptly as such expenses are incurred and are due and
      payable) reasonably incurred by them in connection with investigating or
      defending any such Claim; provided, however, that the indemnity agreement
      contained in this Section 6(b) shall not apply to amounts paid in
      settlement of any Claim if such settlement is effected without the prior
      written consent of such Investor, which consent shall not be unreasonably
      withheld; provided, further, however, that the Investor shall be liable
      under this Agreement (including this Section 6(b) and Section 7) for only
      that amount as does not exceed the net proceeds to such Investor as a
      result of the sale of Registrable Securities pursuant to such Registration
      Statement. Such indemnity shall remain in full force and effect regardless
      of any investigation made by or on behalf of such Indemnified Party and
      shall survive the transfer of the Registrable Securities by the Investors
      pursuant to Section 9. Notwithstanding anything to the contrary contained
      herein, the indemnification agreement contained in this Section 6(b) with
      respect to any preliminary prospectus shall not inure to the benefit of
      any Indemnified Party if the untrue statement or omission of material fact
      contained in the preliminary prospectus was corrected on a timely basis in
      the prospectus, as then amended or supplemented.

                                       12
<PAGE>

            c. Promptly after receipt by an Indemnified Person or Indemnified
      Party under this Section 6 of notice of the commencement of any action
      (including any governmental action), such Indemnified Person or
      Indemnified Party shall, if a Claim in respect thereof is to be made
      against any indemnifying party under this Section 6, deliver to the
      indemnifying party a written notice of the commencement thereof, and the
      indemnifying party shall have the right to participate in, and, to the
      extent the indemnifying party so desires, jointly with any other
      indemnifying party similarly noticed, to assume control of the defense
      thereof with counsel mutually satisfactory to the indemnifying party and
      the Indemnified Person or the Indemnified Party, as the case may be;
      provided, however, that an Indemnified Person or Indemnified Party shall
      have the right to retain its own counsel with the fees and expenses to be
      paid by the indemnifying party, if, in the reasonable opinion of counsel
      retained by the indemnifying party, the representation by such counsel of
      the Indemnified Person or Indemnified Party and the indemnifying party
      would be inappropriate due to actual or potential differing interests
      between such Indemnified Person or Indemnified Party and any other party
      represented by such counsel in such proceeding. The indemnifying party
      shall pay for only one separate legal counsel for the Indemnified Persons
      or the Indemnified Parties, as applicable, and such legal counsel shall be
      selected by Investors holding a majority-in-interest of the Registrable
      Securities included in the Registration Statement to which the Claim
      relates (with the approval of a majority-in-interest of the Initial
      Investors), if the Investors are entitled to indemnification hereunder, or
      the Company, if the Company is entitled to indemnification hereunder, as
      applicable. The failure to deliver written notice to the indemnifying
      party within a reasonable time of the commencement of any such action
      shall not relieve such indemnifying party of any liability to the
      Indemnified Person or Indemnified Party under this Section 6, except to
      the extent that the indemnifying party is actually prejudiced in its
      ability to defend such action. The indemnification required by this
      Section 6 shall be made by periodic payments of the amount thereof during
      the course of the investigation or defense, as such expense, loss, damage
      or liability is incurred and is due and payable.

                                       13
<PAGE>

      7. CONTRIBUTION.

      To the extent any indemnification by an indemnifying party is prohibited
or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable
under Section 6 to the fullest extent permitted by law; provided, however, that
(i) no contribution shall be made under circumstances where the maker would not
have been liable for indemnification under the fault standards set forth in
Section 6, (ii) no seller of Registrable Securities guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be
entitled to contribution from any seller of Registrable Securities who was not
guilty of such fraudulent misrepresentation, and (iii)contribution (together
with any indemnification or other obligations under this Agreement) by any
seller of Registrable Securities shall be limited in amount to the net amount of
proceeds received by such seller from the sale of such Registrable Securities.

      8. REPORTS UNDER THE 1934 ACT.

      With a view to making available to the Investors the benefits of Rule 144
promulgated under the 1933 Act or any other similar rule or regulation of the
SEC that may at any time permit the investors to sell securities of the Company
to the public without registration ("Rule 144"), the Company agrees to:

            a. make and keep public information available, as those terms are
      understood and defined in Rule 144;

            b. file with the SEC in a timely manner all reports and other
      documents required of the Company under the 1933 Act and the 1934 Act so
      long as the Company remains subject to such requirements (it being
      understood that nothing herein shall limit the Company's obligations under
      Section 4(c) of the Securities Purchase Agreement) and the filing of such
      reports and other documents is required for the applicable provisions of
      Rule 144; and

            c. furnish to each Investor so long as such Investor owns
      Registrable Securities, promptly upon request, (i) a written statement by
      the Company that it has complied with the reporting requirements of Rule
      144, the 1933 Act and the 1934 Act, (ii) a copy of the most recent annual
      or quarterly report of the Company and such other reports and documents so
      filed by the Company, and (iii) such other information as may be
      reasonably requested to permit the Investors to sell such securities
      pursuant to Rule 144 without registration.

      9. ASSIGNMENT OF REGISTRATION RIGHTS.

      The rights under this Agreement shall be automatically assignable by the
Investors to any transferee of all or any portion of Registrable Securities if:
(i) the Investor agrees in writing with the transferee or assignee to assign
such rights, and a copy of such agreement is furnished to the Company within a
reasonable time after such assignment, (ii) the Company is, within a reasonable
time after such transfer or assignment, furnished with written notice of (a) the
name and address of such transferee or assignee, and (b) the securities with
respect to which such registration rights are being transferred or assigned,
(iii) following such transfer or assignment, the further disposition of such
securities by the transferee or assignee is restricted under the 1933 Act and
applicable state securities laws, (iv) at or before the time the Company
receives the written notice contemplated by clause (ii) of this sentence, the
transferee or assignee agrees in writing with the Company to be bound by all of
the provisions contained herein, (v) such transfer shall have been made in
accordance with the applicable requirements of the Securities Purchase
Agreement, and (vi) such transferee shall be an "accredited investor" as that
term defined in Rule 501 of Regulation D promulgated under the 1933 Act.

                                       14
<PAGE>

      10. AMENDMENT OF REGISTRATION RIGHTS.

      Provisions of this Agreement may be amended and the observance thereof may
be waived (either generally or in a particular instance and either retroactively
or prospectively), only with written consent of the Company, each of the Initial
Investors (to the extent such Initial Investor still owns Registrable
Securities) and Investors who hold a majority interest of the Registrable
Securities. Any amendment or waiver effected in accordance with this Section 10
shall be binding upon each Investor and the Company.

      11. MISCELLANEOUS.

            a. A person or entity is deemed to be a holder of Registrable
      Securities whenever such person or entity owns of record such Registrable
      Securities. If the Company receives conflicting instructions, notices or
      elections from two or more persons or entities with respect to the same
      Registrable Securities, the Company shall act upon the basis of
      instructions, notice or election received from the registered owner of
      such Registrable Securities.

            b. Any notices required or permitted to be given under the terms
      hereof shall be sent by certified or registered mail (return receipt
      requested) or delivered personally or by courier (including a recognized
      overnight delivery service) or by facsimile and shall be effective five
      days after being placed in the mail, if mailed by regular United States
      mail, or upon receipt, if delivered personally or by courier (including a
      recognized overnight delivery service) or by facsimile, in each case
      addressed to a party. The addresses for such communications shall be:

                  If to the Company:

                  Advanced Biophotonics Inc.
                  125 Wilbur Place, Suite 120
                  Bohemia, NY 11716
                  Attention: Chief Executive Officer
                  Telephone:  (631) 543-3655
                  Facsimile: (631) 244-7960

                                       15
<PAGE>

                  With a copy to:

                  Sichenzia Ross Friedman Ference LLP
                  1065 Avenue of the Americas
                  New York, NY  10018
                  Attention: Gregory Sichenzia, Esq.
                  Telephone: (212) 930-9700
                  Facsimile: (212) 930-9725

If to an Investor: to the address set forth immediately below such Investor's
name on the signature pages to the Securities Purchase Agreement.

                  With a copy to:

                  Ballard Spahr Andrews & Ingersoll, LLP
                  1735 Market Street
                  51st Floor
                  Philadelphia, Pennsylvania  19103
                  Attention: Gerald J. Guarcini, Esq.
                  Telephone: 215-865-8625
                  Facsimile: 215-864-8999

            c. Failure of any party to exercise any right or remedy under this
      Agreement or otherwise, or delay by a party in exercising such right or
      remedy, shall not operate as a waiver thereof.

            d. THIS AGREEMENT SHALL BE ENFORCED, GOVERNED BY AND CONSTRUED IN
      ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS
      MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE, WITHOUT REGARD TO THE
      PRINCIPLES OF CONFLICT OF LAWS. THE PARTIES HERETO HEREBY SUBMIT TO THE
      EXCLUSIVE JURISDICTION OF THE UNITED STATES FEDERAL COURTS LOCATED NEW
      YORK, NEW YORK WITH RESPECT TO ANY DISPUTE ARISING UNDER THIS AGREEMENT,
      THE AGREEMENTS ENTERED INTO IN CONNECTION HEREWITH OR THE TRANSACTIONS
      CONTEMPLATED HEREBY OR THEREBY. BOTH PARTIES IRREVOCABLY WAIVE THE DEFENSE
      OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH SUIT OR PROCEEDING.
      BOTH PARTIES FURTHER AGREE THAT SERVICE OF PROCESS UPON A PARTY MAILED BY
      FIRST CLASS MAIL SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF
      PROCESS UPON THE PARTY IN ANY SUCH SUIT OR PROCEEDING. NOTHING HEREIN
      SHALL AFFECT EITHER PARTY'S RIGHT TO SERVE PROCESS IN ANY OTHER MANNER
      PERMITTED BY LAW. BOTH PARTIES AGREE THAT A FINAL NON-APPEALABLE JUDGMENT
      IN ANY SUCH SUIT OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN
      OTHER JURISDICTIONS BY SUIT ON SUCH JUDGMENT OR IN ANY OTHER LAWFUL
      MANNER. THE PARTY WHICH DOES NOT PREVAIL IN ANY DISPUTE ARISING UNDER THIS
      AGREEMENT SHALL BE RESPONSIBLE FOR ALL FEES AND EXPENSES, INCLUDING
      ATTORNEYS' FEES, INCURRED BY THE PREVAILING PARTY IN CONNECTION WITH SUCH
      DISPUTE.

                                       16
<PAGE>

            e. In the event that any provision of this Agreement is invalid or
      unenforceable under any applicable statute or rule of law, then such
      provision shall be deemed inoperative to the extent that it may conflict
      therewith and shall be deemed modified to conform with such statute or
      rule of law. Any provision hereof which may prove invalid or unenforceable
      under any law shall not affect the validity or enforceability of any other
      provision hereof.

            f. This Agreement, the Notes, the Warrants and the Securities
      Purchase Agreement (including all schedules and exhibits thereto)
      constitute the entire agreement among the parties hereto with respect to
      the subject matter hereof and thereof. There are no restrictions,
      promises, warranties or undertakings, other than those set forth or
      referred to herein and therein. This Agreement and the Securities Purchase
      Agreement supersede all prior agreements and understandings among the
      parties hereto with respect to the subject matter hereof and thereof.

            g. Subject to the requirements of Section 9 hereof, this Agreement
      shall be binding upon and inure to the benefit of the parties and their
      successors and assigns.

            h. The headings in this Agreement are for convenience of reference
      only and shall not form part of, or affect the interpretation of, this
      Agreement.

            i. This Agreement may be executed in two or more counterparts, each
      of which shall be deemed an original but all of which shall constitute one
      and the same agreement and shall become effective when counterparts have
      been signed by each party and delivered to the other party. This
      Agreement, once executed by a party, may be delivered to the other party
      hereto by facsimile transmission of a copy of this Agreement bearing the
      signature of the party so delivering this Agreement.

            j. Each party shall do and perform, or cause to be done and
      performed, all such further acts and things, and shall execute and deliver
      all such other agreements, certificates, instruments and documents, as the
      other party may reasonably request in order to carry out the intent and
      accomplish the purposes of this Agreement and the consummation of the
      transactions contemplated hereby.

            k. Except as otherwise provided herein, all consents and other
      determinations to be made by the Investors pursuant to this Agreement
      shall be made by Investors holding a majority of the Registrable
      Securities, determined as if the all of the Notes then outstanding have
      been converted into for Registrable Securities.

            l. The Company acknowledges that a breach by it of its obligations
      hereunder will cause irreparable harm to each Investor by vitiating the
      intent and purpose of the transactions contemplated hereby. Accordingly,
      the Company acknowledges that the remedy at law for breach of its
      obligations under this Agreement will be inadequate and agrees, in the
      event of a breach or threatened breach by the Company of any of the
      provisions under this Agreement, that each Investor shall be entitled, in
      addition to all other available remedies in law or in equity, and in
      addition to the penalties assessable herein, to an injunction or
      injunctions restraining, preventing or curing any breach of this Agreement
      and to enforce specifically the terms and provisions hereof, without the
      necessity of showing economic loss and without any bond or other security
      being required.

                                       17
<PAGE>

            m. The language used in this Agreement will be deemed to be the
      language chosen by the parties to express their mutual intent, and no
      rules of strict construction will be applied against any party.

                 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       18
<PAGE>

      IN WITNESS WHEREOF, the Company and the undersigned Initial Investors have
caused this Agreement to be duly executed as of the date first above written.

ADVANCED BIOPHOTONICS INC.

/s/ Denis A. O'Connor
-----------------------
Denis A. O'Connor
Chief Executive Officer

AJW PARTNERS, LLC
By:  SMS Group, LLC

/s/ Corey S. Ribotsky
------------------------
Corey S. Ribotsky
Manager

AJW OFFSHORE, LTD.
By:  First Street Manager II, LLC

/s/ Corey S. Ribotsky
-------------------------
Corey S. Ribotsky
Manager

AJW QUALIFIED PARTNERS, LLC
By:  AJW Manager, LLC

/s/ Corey S. Ribotsky
-------------------------
Corey S. Ribotsky
Manager

NEW MILLENNIUM CAPITAL PARTNERS, II, LLC
By:  First Street Manager II, LLC

/s/ Corey S. Ribotsky
-------------------------
Corey S. Ribotsky
Manager

                                       19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]